Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

Capital World Investors (Trades, Portfolio) executed a significant transaction by reducing their holdings in Tandem Diabetes ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Tandem ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

An investigational once-weekly insulin was noninferior to a daily option for patients with type 2 diabetes, but proved risky ...

New research emphasizes that replacing ultra-processed foods with healthier alternatives may help significantly reduce the ...

A news release from the National Institutes of Health (NIH) said that, "scientists are not clear how metformin may prevent ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...